Engineering CAR-T Cells for Next-Generation Cancer Therapy

被引：391
|
作者：
Hong, Mihe [1 ]
Clubb, Justin D. [1 ]
Chen, Yvonne Y. [1 ,2 ,3 ]
机构：
[1] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Parker Inst Canc Immunotherapy Ctr, Los Angeles, CA 90095 USA
来源：
CANCER CELL | 2020年 / 38卷 / 04期
关键词：
CHIMERIC-ANTIGEN-RECEPTOR; FIBROBLAST ACTIVATION PROTEIN; NATURAL-KILLER-CELLS; ANTITUMOR EFFICACY; SUICIDE-GENE; TUMOR MICROENVIRONMENT; 4-1BB COSTIMULATION; CHECKPOINT BLOCKADE; SAFETY SWITCH; TGF-BETA;
D O I：
10.1016/j.ccell.2020.07.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
T cells engineered to express chimeric antigen receptors (CARs) with tumor specificity have shown remarkable success in treating patients with hematologic malignancies and revitalized the field of adoptive cell therapy. However, realizing broader therapeutic applications of CAR-T cells necessitates engineering approaches on multiple levels to enhance efficacy and safety. Particularly, solid tumors present unique challenges due to the biological complexity of the solid-tumor microenvironment (TME). In this review, we highlight recent strategies to improve CAR-T cell therapy by engineering (1) the CAR protein, (2) T cells, and (3) the interaction between T cells and other components in the TME.
引用
收藏
页码：473 / 488
页数：16
相关论文
共 50 条
  • [41] Teaching an old dog new tricks: next-generation CAR T cells
    Tokarew, Nicholas
    Ogonek, Justyna
    Endres, Stefan
    von Bergwelt-Baildon, Michael
    Kobold, Sebastian
    [J]. BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 26 - 37
  • [42] Next-generation CAR T cell therapies for glioblastoma
    Bernstock, Joshua D.
    Gerstl, Jakob V. E.
    Valdes, Pablo A.
    Friedman, Gregory K.
    Chiocca, Antonio
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (762)
  • [43] Next-Generation CAR T-cell Therapies
    Young, Regina M.
    Engel, Nils W.
    Uslu, Ugur
    Wellhausen, Nils
    June, Carl H.
    [J]. CANCER DISCOVERY, 2022, 12 (07) : 1625 - 1633
  • [44] Metabolic engineering for optimized CAR-T cell therapy
    Sarah J. McPhedran
    Gillian A. Carleton
    Julian J. Lum
    [J]. Nature Metabolism, 2024, 6 : 396 - 408
  • [45] Metabolic engineering for optimized CAR-T cell therapy
    Mcphedran, Sarah J.
    Carleton, Gillian A.
    Lum, Julian J.
    [J]. NATURE METABOLISM, 2024, 6 (03) : 396 - 408
  • [46] Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
    Yu, Tao
    Yu, Shao-kun
    Xiang, Yan
    Lu, Kai-Hua
    Sun, Ming
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
    Zhang, Xi-Wen
    Wu, Yi-Shi
    Xu, Tian-Min
    Cui, Man-Hua
    [J]. BIOMOLECULES, 2023, 13 (03)
  • [48] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
    Martin-Otal, Celia
    Lasarte-Cia, Aritz
    Serrano, Diego
    Casares, Noelia
    Conde, Enrique
    Navarro, Flor
    Sanchez-Moreno, Ines
    Gorraiz, Marta
    Sarrion, Patricia
    Calvo, Alfonso
    De Andrea, Carlos E.
    Echeveste, Jose
    Vilas, Amaia
    Rodriguez-Madoz, Juan Roberto
    San Miguel, Jesus
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Lasarte, Juan Jose
    Lozano, Teresa
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [49] HOW CAR-T CELLS BECAME THE HOT RODS OF CANCER THERAPY
    Ledford, Heidi
    [J]. NATURE, 2023, 613 (7945) : 626 - 628
  • [50] Engineering CAR-T cells with an integrated on/off switch
    Juillerat, A.
    Tkach, D.
    Busser, B.
    Temburni, S.
    Valton, J.
    Duclert, A.
    Poirot, L.
    Duchateau, P.
    [J]. HUMAN GENE THERAPY, 2018, 29 (12) : A120 - A121
12345